MedTrace Logo

A New Breath for Malignant Hypertension: Implementation of the HAMA Cohort

NCT03755726 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2026-03-23

No results posted yet for this study

Summary

This registry aims to provide the first prospective, multicentric database of patients with malignant hypertension. It will allow to assess modern epidemiology of the disease, diversity of current management and care pathway, to deepen our pathophysiological knowledges, to modernize the definition of this form of hypertension and its diagnostic criteria. The network that will emerge will finally lead to the opportunity of setting up therapeutic trials and establishing recommendations based on solid scientific evidence.

Conditions

  • Malignant Hypertension

Sponsors & Collaborators

  • Centre Hospitalier de PAU

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-20
Primary Completion
2034-09-20
Completion
2034-09-20

Countries

  • France
  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03755726 on ClinicalTrials.gov